These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23940046)

  • 1. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.
    Dudakovic A; Evans JM; Li Y; Middha S; McGee-Lawrence ME; van Wijnen AJ; Westendorf JJ
    J Biol Chem; 2013 Oct; 288(40):28783-91. PubMed ID: 23940046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells.
    Dudakovic A; Camilleri ET; Lewallen EA; McGee-Lawrence ME; Riester SM; Kakar S; Montecino M; Stein GS; Ryoo HM; Dietz AB; Westendorf JJ; van Wijnen AJ
    J Cell Physiol; 2015 Jan; 230(1):52-62. PubMed ID: 24912092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
    McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
    Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
    Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.
    Schroeder TM; Nair AK; Staggs R; Lamblin AF; Westendorf JJ
    BMC Genomics; 2007 Oct; 8():362. PubMed ID: 17925016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation.
    Man K; Brunet MY; Fernandez-Rhodes M; Williams S; Heaney LM; Gethings LA; Federici A; Davies OG; Hoey D; Cox SC
    J Extracell Vesicles; 2021 Jul; 10(9):e12118. PubMed ID: 34262674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
    Richon VM; Sandhoff TW; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.
    Ali D; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
    Stem Cells Transl Med; 2016 Aug; 5(8):1036-47. PubMed ID: 27194745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
    Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
    Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.
    Sun X; Hasanali ZS; Chen A; Zhang D; Liu X; Wang HG; Feith DJ; Loughran TP; Xu K
    Br J Haematol; 2015 Feb; 168(3):371-83. PubMed ID: 25284154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
    Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
    Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
    Yang PM; Lin PJ; Chen CC
    Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells.
    Valiulienė G; Vitkevičienė A; Navakauskienė R
    Eur J Pharmacol; 2020 Dec; 889():173641. PubMed ID: 33045196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation together with DNA demethylation empowers higher plasticity in adipocytes to differentiate into osteoblasts.
    Cho YD; Kim BS; Kim WJ; Kim HJ; Baek JH; Woo KM; Seol YJ; Ku Y; Ryoo HM
    Gene; 2020 Apr; 733():144274. PubMed ID: 31809844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suberoylanilide hydroxamic acid enhances odontoblast differentiation.
    Kwon A; Park HJ; Baek K; Lee HL; Park JC; Woo KM; Ryoo HM; Baek JH
    J Dent Res; 2012 May; 91(5):506-12. PubMed ID: 22447851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.
    Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
    J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.